TESTOSTERONE SUPPLEMENTATION AND EXERCISE IN ELDERLY MEN
老年男性的睾酮补充和锻炼
基本信息
- 批准号:7604412
- 负责人:
- 金额:$ 72.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-01 至 2008-03-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAgingAndrogensAttenuatedBenefits and RisksBody CompositionChronicComputer Retrieval of Information on Scientific Projects DatabaseDevelopmentDoseDouble-Blind MethodDrug FormulationsElderly manEquilibriumErythrocytosesExerciseFrail ElderlyFundingFutureGelGoalsGrantGrowthHeartInstitutionIntervention TrialMemoryMusclePerformancePersonal SatisfactionPhysical FunctionPhysiologicalPlacebosProstateRandomizedRangeResearchResearch PersonnelResistanceResourcesRisk BehaviorsRoleSerumSleepSourceSupplementationTestosteroneTrainingUnited States National Institutes of Healthage relatedbonedesignfrailtyfunctional restorationmenolder menplacebo controlled studyprevent
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The long-term goal of this project is to better understand the physiological significance of the age-related decline in serum testosterone (T) levels and the role of T supplementation, with and without exercise, in attenuating the reduced physical function and frailty found in aging men. Studies suggest that T replacement in healthy elderly men has beneficial effects on body composition, muscle, bone, memory and behavior, but the risks of chronic treatment, especially on the prostate, heart and sleep quality, are not entirely clear. Therefore, it is most desirable to supplement into the lowest "effective" range in elderly men. However, the effects of lower than usual replacement T doses have not been well studied. Furthermore, the possible important interaction of exercise to enhance the positive effects of T supplementation yet mitigate the possible side effects has not been studied in older men. A randomized, double-blinded, placebo-controlled study (complete, balanced, 2-way factorial design) will be performed. The factors are testosterone dose (placebo, low-dose [25 mg/d], usual-dose [50 mg/d]) crossed with progressive resistance training (some versus none). This study will determine: 1) the beneficial (body composition, physical performance, and functional performance) and adverse (erythrocytosis, and prostate growth) effects of low-dose versus usual replacement-dose T therapy (as T gel; AndroGelTM), in healthy older men with low-normal to slightly low serum T levels; and 2) the possible positive interaction between low-dose T supplementation and progressive resistance training to further enhance anabolic and functional effects while reducing side effects. These studies will provide important new information regarding the risk/benefit profile of low-dose T supplementation compared to conventional T replacement doses. These studies will also influence future development of androgen formulations and guide intervention trials to assess the benefits and risks of T treatment, in both healthy and frail elderly men, to prevent frailty and help restore function.
该副本是利用众多研究子项目之一
由NIH/NCRR资助的中心赠款提供的资源。子弹和
调查员(PI)可能已经从其他NIH来源获得了主要资金,
因此可以在其他清晰的条目中代表。列出的机构是
对于中心,这不一定是调查员的机构。
该项目的长期目标是更好地理解血清睾丸激素水平与年龄相关的生理意义,以及补充有或没有运动的补充t的作用,在减少衰老男性中的身体机能和脆弱性方面的降低。研究表明,健康老年男性的T替代对身体成分,肌肉,骨骼,记忆和行为具有有益的影响,但是慢性治疗的风险,尤其是对前列腺,心脏和睡眠质量的风险,并不完全清楚。因此,最希望将老年男性的“有效”范围补充为最低的“有效”范围。但是,尚未对较低的替代剂量的效果进行很好的研究。此外,在老年男性中尚未研究锻炼可能增强T的积极影响但减轻可能的副作用的重要相互作用。 将进行一项随机,双盲,安慰剂对照研究(完整,平衡,2向阶乘设计)。这些因素是睾丸激素剂量(安慰剂,低剂量[25 mg/d],通常的剂量[50 mg/d]),并进行了进行性耐药性训练(有些对无)。这项研究将确定:1)低剂量与通常的替代剂量T疗法(作为T Gel; Androgeltm)的有益(身体成分,身体性能和功能性能)和不良(红细胞增多和前列腺生长)的影响,在健康的老年男性中,低正常至略低于血清T水平; 2)低剂量T补充和进行性耐药性训练之间可能存在正相互作用,以进一步增强合成代谢和功能效应,同时减少副作用。这些研究将提供有关与常规T替代剂量相比,补充低剂量T的风险/收益概况的重要新信息。这些研究还将影响雄激素配方的未来发展,并指导干预试验,以评估健康和虚弱的老年男性中T治疗的益处和风险,以防止脆弱并帮助恢复功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert S Schwartz其他文献
Robert S Schwartz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert S Schwartz', 18)}}的其他基金
Pioglitazone & Exercise Effects on Older Aldults with MCI and Metabolic Syndrome
吡格列酮
- 批准号:
7663152 - 财政年份:2008
- 资助金额:
$ 72.81万 - 项目类别:
Pioglitazone & Exercise Effects on Older Aldults with MCI and Metabolic Syndrome
吡格列酮
- 批准号:
7384010 - 财政年份:2008
- 资助金额:
$ 72.81万 - 项目类别:
Pioglitazone & Exercise Effects on Older Aldults with MCI and Metabolic Syndrome
吡格列酮
- 批准号:
7891161 - 财政年份:2008
- 资助金额:
$ 72.81万 - 项目类别:
TESTOSTERONE SUPPLEMENTATION AND EXERCISE IN ELDERLY MEN
老年男性的睾酮补充和锻炼
- 批准号:
7719462 - 财政年份:2008
- 资助金额:
$ 72.81万 - 项目类别:
24 H ENERGY EXPENDITURE AND NUTRIENT OXIDATION IN YOUNG AND OLDER ADULTS
24 H 年轻人和老年人的能量消耗和营养氧化
- 批准号:
7377777 - 财政年份:2006
- 资助金额:
$ 72.81万 - 项目类别:
TESTOSTERONE SUPPLEMENTATION AND EXERCISE IN ELDERLY MEN
老年男性的睾酮补充和锻炼
- 批准号:
7377826 - 财政年份:2006
- 资助金额:
$ 72.81万 - 项目类别:
24 H ENERGY EXPENDITURE AND NUTRIENT OXIDATION IN YOUNG AND OLDER ADULTS
24 H 年轻人和老年人的能量消耗和营养氧化
- 批准号:
7200541 - 财政年份:2005
- 资助金额:
$ 72.81万 - 项目类别:
VASCULAR ANGIOGENESIS IN RESPONSE TO DRUG ELUTING STENT IMPLANT
药物洗脱支架植入后的血管生成
- 批准号:
7181532 - 财政年份:2005
- 资助金额:
$ 72.81万 - 项目类别:
TESTOSTERONE SUPPLEMENTATION AND EXERCISE IN ELDERLY MEN
老年男性的睾酮补充和锻炼
- 批准号:
7200602 - 财政年份:2005
- 资助金额:
$ 72.81万 - 项目类别:
Testosterone Supplementation and Exercise in Elderly Men
老年男性的睾酮补充和锻炼
- 批准号:
6614084 - 财政年份:2004
- 资助金额:
$ 72.81万 - 项目类别:
相似国自然基金
温度作用下CA砂浆非线性老化蠕变性能的多尺度研究
- 批准号:12302265
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于波动法的叠层橡胶隔震支座老化损伤原位检测及精确评估方法研究
- 批准号:52308322
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
微纳核壳结构填充体系构建及其对聚乳酸阻燃、抗老化、降解和循环的作用机制
- 批准号:52373051
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
东北黑土中农膜源微塑料冻融老化特征及其毒性效应
- 批准号:42377282
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
高层建筑外墙保温材料环境暴露自然老化后飞火点燃机理及模型研究
- 批准号:52376132
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Steroid Hormone Pathways Regulating BPH and LUTS
调节 BPH 和 LUTS 的类固醇激素途径
- 批准号:
10601867 - 财政年份:2023
- 资助金额:
$ 72.81万 - 项目类别:
A longitudinal, nationally representative study of cognition-related effects of breast cancer and its treatment
关于乳腺癌及其治疗的认知相关影响的纵向、全国代表性研究
- 批准号:
10709517 - 财政年份:2022
- 资助金额:
$ 72.81万 - 项目类别:
Preventing Falls and Frailty in Prostate Cancer Survivors: GET FIT Prostate
预防前列腺癌幸存者跌倒和虚弱:GET FIT Prostate
- 批准号:
9596188 - 财政年份:2018
- 资助金额:
$ 72.81万 - 项目类别:
Aromatase Inhibitors and Weight Loss in Severely Obese Men with Hypogonadism
芳香酶抑制剂与患有性腺功能减退症的严重肥胖男性的减肥
- 批准号:
9942488 - 财政年份:2017
- 资助金额:
$ 72.81万 - 项目类别:
Effects of Androgen Deprivation Therapy on Preclinical Symptoms of Alzheimer's Disease
雄激素剥夺疗法对阿尔茨海默病临床前症状的影响
- 批准号:
9364864 - 财政年份:2017
- 资助金额:
$ 72.81万 - 项目类别: